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ABSTRACT
The insulin receptor (IR) is a transmembrane receptor which recognizes and binds the hormone insulin. We describe 
two models that were devised to explore the role of IR over-expression on T-lymphocytes and their chemotactic motility 
in the progression of type 1 diabetes. FVB/NJ-CD3-3×FLAG-mIR/MFM mice were generated to selectively over-express 
3×FLAG tagged murine IR in T-lymphocytes via an engineered CD3 enhancer and promoter construct. Insertion of the 
3×FLAG-mIR transgene into FVB/NJ mice, a known non-autoimmune prone strain, lead to a minor population of detect-
able 3×FLAG-mIR tagged T-lymphocytes in peripheral blood and the presence of a few lymphocytes in the pancreas 
of the Tg+/- compared to age matched Tg-/- control mice. In order to induce stronger murine IR over-expression then 
what was observed with the CD3 enhancer promoter construct, a second system utilizing the strong CAG viral promoter 
was generated. This system induces cell specific IR over-expression upon Cre-Lox recombination to afford functional 
3×FLAG tagged murine IR with an internal eGFP reporter. The pPNTlox2-3×FLAG-mIR plasmid was constructed and 
validated in HEK-Cre-RFP cells to ensure selective Cre recombinase based 3×FLAG-mIR expression, receptor ligand 
affinity towards insulin, and functional initiation of signal transduction upon insulin stimulation.
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INTRODUCTION
The insulin receptor (IR) is a transmembrane receptor known for 
binding and being activated by insulin [1,2]. Signaling through the IR 
leads to the activation of multiple downstream modulators which control 
events such as protein translation, autophagy, apoptosis, oxidative stress, 
cell mobility/chemotaxis, gene transcription, and cellular differentiation 
and/or cell growth [3,4]. Since the IR is such a strong mediator of cellular 
homeostasis it has long been studied for its potential role in numerous 
disease states including: Alzheimer’s disease, cancer, and both type 1 
(T1D) and type 2 diabetes [4-8].
It has been shown that activated human peripheral blood lymphocytes 
(both CD4+ and CD8+) up-regulate surface IR expression and display 
increased chemotaxis toward insulin [9]. Insulin is also chemotactic for 
macrophages, which infiltrate into the islets of non-obese diabetic (NOD) 
mice [10]. Previous data from our laboratory highlights the capability 
of IR surface expression levels as a defining component in lymphocyte 
directed pathogenesis of T1D [7]. In an effort to understand the role of 
IR over-expression on lymphocyte chemotaxis in the progression of 
T1D, two unique IR over-expression models systems were developed. 
Understanding the mechanism driving lymphocyte migration towards the 
pancreas and into the insulin producing islet of Langerhans is necessary 
to design novel therapeutic preventatives to treat T1D.
MATERIALS AND METHODS
Plasmid validation
Research involving recombinant DNA use was approved by the 
Institutional Biosafety Committee at the University of Toledo prior to 
being carried out. The pNeZBCD3-3×FLAG-mIR plasmid (modified 
from pNeZB a gift from Dr. Lee, Mayo Clinic, MN) was used to generate 
FVB/NJ-CD3-3×FLAG-mIR transgenic mice. Additionally, insertion of 
the PPT-3×FLAG-mIR gene (approximately 4.1 Kb) into the pPNTlox2 
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(Dr. Howard, University of Toledo, OH [11]) backbone afforded the 
formation of the pPNTlox2-3×FLAG-mIR plasmid. Both plasmids 
were sequenced at the University of Michigan’s DNA Sequencing 
Core Facility (Ann Arbor, MI). Sequencing data was analyzed using 
FinchTV software (Geospiza Inc.) and the NCBI sequence alignment 
tool. Sequencing primers can be found in Table S1.
Generation of FVB/NJ-CD3-3×FLAG-mIR/MFM mice
In brief, FVB/NJ-CD3-3×FLAG-mIR/MFM transgenic mice were 
generated at the Ohio State University’s Transgenic Core Facility 
(Columbus, OH) using the pronuclear injection method with DNA 
from the pNeZBCD3-3×FLAG-mIR plasmid. Founder tail clips were 
polymerase chain reaction (PCR) genotyped for presence of transgene 
3×FLAG and endogenous murine β-globin. Mice were characterized 
as either FVB/NJ-CD3-3×FLAG-mIR/MFM transgene positive (Tg+/-) 
or transgene negative (Tg-/-). Mice were bred and housed in specific 
pathogen free conditions in the Department of Laboratory Animal 
Resources care facility at the University of Toledo (Toledo, OH) under 
an approved animal protocol.
Peripheral blood lymphocyte analysis
Approximately 100 µl of blood was collected in 200 µl of ACD 
buffer (Becton Dickinson) and processed to remove all red blood 
cells prior to lymphocyte staining. Cells were treated with TruStain 
FcX affinity purified anti-mouse CD16/32 Fc block (BioLegend) and 
stained with DYKDDDDK (FLAG) Tag specific FITC-anti-Flag M2 
mAb (Sigma Cat. #F4049) and PE-anti-mouse CD3e mAb (eBioscience 
Cat. #eBio500A2). Cell samples were analyzed on a BD FACSCaliber 
cytometer (BD Biosciences).
 Tissue immunohistochemistry and imaging
Pancreatic tissue was fixed in 10% Neutral Buffered Formalin, paraffin 
embedded and cut in 5 µm thick sections. Sections were H&E stained 
and imaged at 20 × with a Nikon Eclipse Ti microscope.
Cell culture and transfection
HEK293T (ATCC) cells were grown in DMEM (ATCC) with 10% 
FBS (Atlanta Biologicals) and 1% penicillin/streptomycin (Mediatech 
Inc). HEK-Cre-RFP (GenTarget, Inc.) cells were grown in the same 
media, with puromycin (ThermoFisher) selection (0.5 µg/ml), to elicit 
a selective pressure to ensure Cre recombinase expression. HEK-293T 
(HEK-Cre-) and HEK-Cre-RFP (HEK-Cre+) cells were transfected 
via Lipofectamine 3000 (Invitrogen) and were analyzed 48 h post 
transfection.
Quantitative real-time PCR analysis
Cell preparations were lysed and total mRNA was purified using 
the RNeasy mini kit (Qiagen). An additional DNase treatment step was 
carried out to remove any contaminating plasmid or nucleotide product. 
Total cDNA was synthesized using M-MLV Reverse Transcriptase 
(ThermoFisher) and quantitated via the BioSpec-nano (Shimadzu 
Biotech). Each quantitative real-time PCR (qRT-PCR) was performed 
in triplicate using equivalent amounts of cDNA template. Amplification 
was performed using Absolute qRT-PCR SYBR mastermix and a CFX96 
system Thermocycler (Bio-Rad). Human Glyceraldehyde-3 phosphate 
dehydrogenase (hGAPDH) was used to normalize the amount of relative 
mRNA using the delta Ct method for quantification.
DNA qRT-PCR was carried out following transfection to validate 
plasmid recombination in the presence of Cre recombinase. DNA was 
purified using the DNeasy Blood & Tissue kit (Qiagen). DNA qRT-
PCR analysis was carried out in triplicate with primers to highlight Cre 
recombination and ablation of the decoy Lac-Z gene. All primers used 
in qRT-PCR analysis are listed in Table S2. A schematic representa-
tion of Cre recombinase inducible gene expression of 3×FLAG-mIR 
in the absence (-) or presence (+) of the enzyme Cre recombinase and 
associated qRT-PCR primers used during recombination analysis can 
be found in Figure S1.
Protein extraction and western blot
Total protein extractions for use in the identification of the Lac-Z gene 
product beta-Galactosidase (LacZ) and FLAG-tagged mIR protein were 
carried out in RIPA lysis buffer (ThermoFisher). Protein extractions for 
use in the identification of phosphorylated-insulin receptor β-subunit 
(phos-IRβ) protein as well as FLAG resin immunoprecipitation were car-
ried out in Native lysis buffer (Abcam). HALT Protease inhibitor cocktail 
(ThermoFisher) was added to both lysis buffers. Protein concentrations 
were quantified by Pierce BCA Protein Assay Kit (ThermoFisher).
Protein samples were prepared in either Pierce Lane Marker Reducing 
or Non-Reducing Sample Buffer (ThermoFisher) prior to SDS PAGE 
electrophoresis. Proteins were transferred onto polyvinylidene fluoride 
membrane (EMD Millipore). Membranes utilized for the detection of 
LacZ and FLAG were blocked with 5% non-fat dry milk, while mem-
branes utilized for phos-IRβ detection were blocked with 5% bovine 
serum albumin (BSA). Selective detection of protein was carried out 
utilizing the following antibodies: anti-DYKDDDDK FLAG (Sigma-Al-
drich Cat. #F2555), anti-phospho-Insulin Receptor beta (Santa Cruz 
Cat. #sc-81500), and anti-beta-Galactosidase directly conjugated to the 
enzyme HRP (Horseradish peroxidase, Abcam Cat. #ab191357). Goat 
anti-mouse secondary antibody (Santa Cruz Cat. #sc-2005) was used 
for identification of phos-IRβ and goat anti-rabbit secondary antibody 
(Santa Cruz Cat. #sc-2004) was used for identification of 3×FLAG 
protein. Protein bands were visualized by chemiluminescence via Clar-
ity Western ECL substrate (Bio-Rad). Images were analyzed using the 
Bio-Rad chemi Doc XRS+ image analyzer. Positive control proteins 
include: recombinant E. coli LacZ protein (Abcam) and Amino-terminal 
FLAG-BAP™ Fusion protein (Sigma-Aldrich).
Flow cytometry and fluorescence activated cell sorting
Flow cytometry was carried out to identify the presence of surface 
expressed 3×FLAG tagged mIR protein. Cells were treated with TruStain 
FcX affinity purified anti-mouse CD16/32 Fc block (BioLegend) and 
stained with DYKDDDDK (FLAG) Tag specific polyclonal Alexa Fluor® 
647 conjugated rabbit antibody, detected in the allophycocyanin (APC) 
channel (Cell Signaling Technology, cat#3916s). Cell samples were 
analyzed on a BD FACSCaliber cytometer (BD Biosciences).
In order to make a stable HEK-Cre+ 3×FLAG-mIR expressing cell 
line, the pPNTlox2-3×FLAG-mIR plasmid was linearized with Afl-II 
and Spe-I to remove all residual bacterial components (Fig. S1). The 
linearized expression cassette was transfected into HEK-Cre+ expressing 
cells to allow non-specific homologous recombination to occur. Cells 
were stained for 3×FLAG tagged mIR protein and sorted to recover eGPF 
and APC double positive cells. The FACS sorted double positive cells, 
which will be referred to as the 3×FLAGmIR cell line, were allowed 
to recover prior to two additional rounds of cell sorting to ensure gene 
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integration and protein expression. Cells were sorted using the BD 
FACSAria IIu flow cytometer (BD).
IR stimulation assay
To assess the functionality of the 3×FLAG-mIR and test its ability to 
initiate proper phos-IRβ, once insulin binds to the IR, an insulin stimula-
tion experiment was performed. Cells were serum starved in 0.01% FBS 
containing DMEM medium for 16–18 h prior to stimulation. Cells were 
left unstimulated or stimulated with 100 nM of insulin (Sigma-Aldrich) 
for 2 min at room temperature. After treatment, the cells were lysed to 
extract protein for FLAG resin immunoprecipitation and western blot 
analysis. Insulin stimulated HEK-Cre+ non-immunoprecipitated cell 
lysate was utilized as the positive control for phos-IRβ detection due 
to their presence of native IR. Inversely, HEK-Cre+ cell lysates were 
utilized as a negative control for the detection of DYKDDDDK FLAG 
phos-IRβ after resin column immunoprecipitation due to their lack of 
3×FLAG expression.
DYKDDDDK FLAG resin immunoprecipitation
Protein extracts from the IR stimulation assay were subjected to 
immunoprecipitation of DYKDDDDK FLAG-tagged protein via an 
anti-DYKDDDDK G1 affinity resin (GenScript L00432-1) to separate 
native IR from the 3×FLAG-mIR. Immunoprecipitated proteins were 
eluted from the resin in PAGE sample buffer via boiling.
IR binding titration
The 3×FLAG-mIR cell line and HEK-Cre+ cells were assessed via 
an IR binding titration assay. Cells were incubated with various sample 
concentrations of biotinylated-insulin (Dr. Finn, University of Pittsburg, 
PA) ranging from 1 × 10−7 M to 1 × 10−13 M, for 45 min at 4°C. Cells 
were stained with Streptavidin Alexa Fluor® 647 Conjugate (Invitrogen) 
secondary reagent and analyzed on a BD FACSAriaIIu cytometer.
Cell immunohistochemistry and imaging
HEK-Cre+ cells and the 3×FLAG-mIR cell line were grown out in 
24 well plates on glass slides. The HEK-Cre+ cells were transfected 
with the pPNTlox2 or the pPNTlox2-3×FLAG-mIR plasmid and stained 
48 h post transfection. All samples were incubated with the plasma 
membrane dye, Cell Navigator™ Cell Plasma Membrane Staining 
Kit (AAT Bioquest). Following plasma membrane staining, cells were 
fixed with 4% paraformaldehyde, blocked with 2% BSA, and stained 
with DYKDDDDK FLAG-tagged specific polyclonal Alexa Fluor® 647 
conjugated antibody (Cell Signaling Technology). Cells were mounted 
to glass microscope slides via DAPI Fluoromount-G® (SouthernBiotech) 
and dried. Image analysis was carried out utilizing a Leica TCS SP5 
multiphoton laser scanning confocal microscope (Leica Microsystems) 
using a 63 × 1.4 NA lens.
RESULTS
FVB/NJ-CD3-3×FLAG-mIR/MFM mice analysis
The pNeZBCD3-3×FLAG-mIR plasmid (Fig. 1A) was used to 
generate FVB/NJ-CD3-3×FLAG-mIR transgenic mice. FVB/NJ-CD3-
3×FLAG-mIR mice express a 3×FLAG-mIR transgene insert which 
encodes a full length mIR containing an N-terminal 3×FLAG tagged 
α-subunit and full length β-subunit as seen in the native mouse INSR 
gene. The endogenous signal peptide coding sequence was deleted and 
replaced with a pre-protrypsin (PPT) signal peptide. The PPT-3×FLAG-
mIR transgene was placed downstream of an engineered CD3 enhancer 
and promoter construct to elicit T-lymphocyte directed transgene over-ex-
pression. Tg+/- FVB/NJ-CD3-3×FLAG-mIR mice express detectable 
3×FLAG protein on T-lymphocytes found in peripheral blood (Fig. 1B, 
dotted line) and spleen (data not shown). Comparisons of H&E stained 
pancreatic tissue slides shows lymphocytes in Tg+/- mice compared to 
age matched 6 week old Tg-/- mice (Fig. 1C vs. Fig. 1D). Heart, liver, 
lung and kidney were all negative for 3×FLAG expressing T-lympho-
cytes in either Tg+/- or Tg-/- mice (data not shown).
pPNTlox2-3×FLAG-mIR plasmid transfection analysis
The PPT-3×FLAG-mIR gene was cloned and sequence verified 
into the pPNTlox2 parent vector to form the pPNTlox2-3×FLAG-mIR 
plasmid (Fig. 2A). The pPNTlox2-3×FLAG-mIR plasmid contains a 
CAG promoter driven Cre-Lox based inducible system that expresses 
the Lac-Z gene as a decoy in the absence of Cre and the mIR gene 
cassette and a non-covalently linked eGFP reporter in the presence of 
Cre (Fig. S1). Transfection with the pPNTlox2-3×FLAG-mIR plasmid 
into HEK-Cre- and HEK-Cre+ cells elicits Cre recombination selec-
tively in the Cre+ cells, wherein a distinct population of double positive 
3×FLAG-mIR (APC) and eGFP positive cells can be observed by flow 
cytometry (Fig. 2B vs. Fig. 2C, upper right quadrant).
Figure 1. Analysis of FVB/NJ-CD3-3×FLAG-mIR transgenic mice. A. 
Plasmid map of pNeZBCD3-3×FLAG-mIR. B. Flow cytometry detection of 
DYKDDDDK (FLAG) tag specific lymphocytes in peripheral blood of age 
matched Tg+/- (dotted line) and Tg-/- mice (solid line). C and D. Pancreatic 
Islet H&E staining from age matched 6 week old Tg-/- and Tg+/- mice. 
Images were taken at 20 × magnification, scale bar represents 100 µm.
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Figure 2. pPNTlox2-3×FLAG-mIR transfection analysis. A. Plasmid map of pPNTlox2-3×FLAG-mIR. B and C. Cytometry detection of FLAG tag specific 
polyclonal Alexa Fluor® 647 conjugated APC and eGFP via transfections with pPNTlox2-3×FLAG-mIR in HEK-Cre- (B) and HEK-Cre+ cells (C). A total of 
10000 events were recorded for all samples. Results were confirmed in a total of three separate experiments. D-F. qRT-PCR results via transfection with 
pPNTlox2-3×FLAG-mIR in HEK-Cre-(open bar) and HEK-Cre+ cells (solid bars). Samples were performed in triplicate, significance of a P value ≤ 0.05 is 
indicated by an asterisk (*). G. Western blot analysis for the detection of LacZ protein in HEK cells transfected with pPNTlox2 or pPNTlox2-3×FLAG-mIR. 
Equivalent amounts of total protein extract were run in reducing conditions (12 μg) for all experimental samples. Recombinant beta-lactamase protein 
(LacZ+) was included as a positive control (100 ng). Results were confirmed in a total of three separate experiments.
Additional evidence of selective recombination upon transfection 
in the presence of Cre recombinase can be seen at both the genetic 
(Fig. 2D-2F) and protein (Fig. 2G) level. Cre mRNA is only expressed 
in Cre+ cells (Fig. 2D). Ablation of the Lac-Z gene is observed by a 
decrease of LacZ mRNA expression in HEK-Cre+ cells (Fig. 2E). Plas-
mid recombination in the presence of Cre recombinase was detected in 
HEK-Cre+ via the production of a DNA specific recombination gene 
product (Fig. 2F). Western blot analysis from transfected HEK-Cre+ 
cells support that a reduction of LacZ mRNA correlates to a reduction 
in LacZ protein production after transfection with both the pPNTlox2-
3×FLAG-mIR and pPNTlox2 plasmids (Fig. 2G).
3×FLAG-mIR cell line generation and analysis
HEK-Cre+ cells were transfected with the linear pPNTlox2-3×FLAG-
mIR expression cassette and were sorted three times to isolate the 
3×FLAG-mIR cell line which is double positive for the expression of 
3×FLAG-mIR and the eGFP reporter. The 3×FLAG-mIR cell line was 
characterized to determine the expression of 3×FLAGmIR and the 
ability to bind biotinylated-insulin in comparison to HEK-Cre+ cells 
(Fig. 3). FLAG reactive antibody strongly stained the 3×FLAG-mIR 
cell line compared to the HEK-Cre+ cells (Fig. 3A solid line vs. dotted 
line). The HEK-Cre+ cells and the 3×FLAG-mIR cell line both express 
native endogenous IR. However, 3×FLAG-mIR cells bind increased 
amounts of biotinylated-insulin upon insulin titration specifically at 
concentrations of 1 × 10-7 M and 1 × 10-8 M compared to HEK-Cre+ 
cells (Fig. 3B and 3C solid lines vs. dotted lines).
Western blot analysis specific for 3×FLAG detection reveals recom-
binant 3×FLAG-mIR protein production in only the 3×FLAG-mIR cell 
line (Fig. 4A). Samples run in reducing conditions identify detectable 
3×FLAG tagged α-subunit at 135 kD and the full length 3×FLAG tagged 
Insulin pro-receptor (αβ) 230 kDa, matching previously reported IR 
molecular weights [12-14]. Non-reducing conditions detect a single 
band above the 250 kDa protein marker, which represents the mature 
fully assembled 3×FLAG-mIR containing two αβ heterodimers matching 
identified assembled IR molecular weights [12-14].
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Figure 3. Flow cytometry analysis of the 3×FLAG-mIR cell line. A. Flow cytometry detection of FLAG tag specific polyclonal Alexa Fluor® 647 conju-
gated APC in untransfected HEK-Cre+ cells (dotted line) and the 3×FLAG-mIR cell line (solid line). A total of 10000 events were recorded for all samples. 
Results were confirmed in a total of three separate experiments. B and C. Flow cytometry detection of HEK-Cre+ (dotted line) and the 3×FLAG-mIR cell 
line (solid) incubated with biotinylated-insulin and detected via streptavidin-APC. Data represents cells treated with1 × 10-8 M (B) 1 × 10-7 M (C) biotinylat-
ed-insulin. A total of 10000 events were recorded for all samples. Results were confirmed in two titration experiments.
Figure 4. Western blot analysis of the 3×FLAG-mIR cell line. A. Analysis of protein from HEK-Cre+ and the 3×FLAG-mIR cell line. Extracted pro-
tein was loaded in equivalent amounts (10 μg) for all samples in both reducing and non-reducing conditions and were stained to detect FLAG protein. 
Reducing conditions identify the 230 kDa Insulin pro-Receptor (αβ) and the 135 kDa mIR α-subunit in 3×FLAG-mIR cells. Non-reducing conditions 
identify the intact mature 3×FLAG-mIR 2(αβ) heterodimer as a single band above 250 kDa. Recombinant BAP-FLAG positive control protein is detected 
at 49 kDa. Results were confirmed in two separate experiments, (B) and (C). Analysis of HEK-Cre+ and the 3×FLAG-mIR cell line following 100 nM 
insulin stimulation. Protein extracts were immunoprecipitated via an anti-DYKDDDDK G1 affinity resin. Anti-phos-IRβ specific primary antibody was to 
detect phosphorylated β-subunit at 95 kDa. B. Equivalent amounts of immunoprecitiated proteins were utilized (2.5 μg), while non-immunoprecipitated 
stimulated HEK-Cre+ cell extract (10 μg) served as the phos-IRβ stimulated positive control. C. HEK-Cre+ immunoprecipitated cell extracts produced no 
detectable band. Results for the generation of specific phos-IRβ stimulated products in 3×FLAG-mIR cells were validated in three separate stimulation 
and immunoprecipitation experiments.
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To selectively assess the ability of the 3×FLAG tagged mIR to bind 
insulin and undergo proper internal phosphorylation of the IR β-sub-
unit, similar to the native IR [1,15-16] an insulin stimulation assay was 
performed. Following the insulin stimulation assay cell extracts were 
subject to immunoprecipitation with a FLAG resin to recover only 
FLAG expressing proteins prior to detection of phos-IRβ known to be 
detected at 95kDa [16]. Figure 3B and 3C clearly illustrates that only 
immunoprecipitated FLAG tagged mIR protein from the 3×FLAG-mIR 
cell line contains detectable phos-IRβ. HEK-Cre+ cells are able to initiate 
proper phosphorylated β-subunit upon insulin stimulation prior to resin 
immunoprecipitation (Fig. 4B), but yield no detectable product after 
immunoprecipitation due to their lack of FLAG expression (Fig. 4C).
Immunohistochemical staining analysis of transfected HEK-Cre+ and 
the 3×FLAG-mIR cell line was performed (Fig. 5). Equivalent staining 
intensities and microscope settings were utilized for all images. All 
images display intact viable cells in the bright field panels, consistent 
nuclei staining, and detectable plasma membrane staining. Cells trans-
fected with the pPNTlox2 plasmid were used as the negative control. 
Cells transfected with pPNTlox2-3×FLAG-mIR plasmid detectable 
eGFP, localized with intense detectable 3×FLAG-tagged protein in a 
low proportion of cells. The 3×FLAG-mIR cell line displays a dramatic 
amount of eGFP protein localized with high intensity of detectable 
3×FLAG-tagged protein in a high proportion of cells. When overlaid 
the 3×FLAG-mIR stain and the plasma membrane stain to merge 
directly on top of one another, providing evidence for 3×FLAG-mIR 
localization within the plasma membrane.
Figure 5. Immunohistochemical analysis of transfected HEK Cre+ and 3×FLAG-mIR cells. The 3×FLAG-mIR cell line and HEK-Cre+ cells transfected 
with either pPNTlox2 or pPNTlox2-3×FLAG-mIR were stained and imaged via laser scanning confocal microscopy. Equivalent staining and detection 
was carried out for all samples, scale bar is equal to 25 µm. All images display intact cells in the bright field panels, nuclei staining via DAPI (blue), and 
plasma membrane staining via Cell Navigator® Plasma Membrane Stain (magenta). The reporter eGFP is displayed in green, while detectable FLAG 
protein is displayed in red. Control cells transfected with pPNTlox2 can be found in the top panels. Cells transfected with pPNTlox2-3×FLAG-mIR can 
be found in the middle panels. The 3×FLAG-mIR cell line samples are found in the bottom panels. Staining experiments were repeated twice.
DISCUSSION
The IR is the key mediator for cellular insulin stimulation and 
glucose uptake [17]. The IR spans the plasma membrane of a cell 
and contains both intracellular and extracellular portions, as well as a 
transmembrane spanning domain [18-19]. Activation of the IR induces 
a vast array of physiological and metabolic effects, most notably the 
uptake of glucose and the conversion of excess glucose into glycogen 
[2-4,17]. While much is known about the signaling and metabolic role 
of the IR there is still much to be uncovered about the potential role of 
the IR in the pathogenesis of T1D.
Previous data from our laboratory shows the importance of IR 
surface expression levels as a key modulator in lymphocyte directed 
pathogenesis of T1D [7]. Purified lymphocytes from spleens of diabetic 
NOD mice were sorted into low and high mIR expressing populations 
and then adoptively transferred into irradiated recipient mice [7]. Re-
cipient mice that received the mIR high expressing lymphocytes went 
on to develop insulitis and rapid diabetes while mice that received 
mIR low expressing transfers did neither [7]. This evidence illustrates 
a novel hypothesis for high density insulin receptors on the surface of 
T-lymphocytes as a driving factor for immune trafficking to the pancreas 
during the progression of T1D.
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Based on these findings the FVB/NJ-CD3-3×FLAG-mIR/MFM 
mouse was developed to assess T-lymphocyte mIR over-expression in 
a non-autoimmune prone strain of mice. The data collected from the 
transgenic model illustrates that additional expression of the mIR can 
cause the presence of T-lymphocytes in the pancreas in a non-antigenic 
specific chemotactic manner. Although Tg+/- mice expressed detectable 
3×FLAG positive lymphocytes in peripheral blood, the over-all CD3 
and FLAG specific populations were relatively lower than expected. 
Tg+/- mice displayed a range of 10.2%–15.8% CD3-FLAG positive 
lymphocytes in peripheral blood compared to that of roughly 2.5% found 
in Tg-/- mice (data not shown). The limiting factor for strong induction 
of mIR over-expression in the FVB/NJ-CD3-3×FLAG-mIR/MFM 
model is most likely due to the CD3 enhancer promoter construct. The 
novel findings linking IR over-expression to detectable lymphocytes 
in the pancreas of a non-autoimmune background sets the stage for 
a continued effort to determine the physiological implications of IR 
over-expression in the NOD T1D murine model to determine whether 
antigen specificity or the chemotactic nature of the IR is driving initial 
lymphocytes towards the pancreas.
The presented CAG viral promoter driven Cre-Lox system was suc-
cessfully validated through both transfection and stable gene integration 
in HEK-Cre+ cells. The gene integration observed in vitro provides 
confidence for use of the CAG transgene in future in vivo transgenic 
animal applications. This system induced cell specific Cre restricted 
expression of functional 3×FLAG tagged mIR and the associated eGFP 
reporter. Validation of this system was necessary prior to generation of 
floxed NOD-3×FLAG-mIR/MFM mice. The floxed NOD-3×FLAG-mIR/
MFM mice will be generated for mating with commercially available 
transgenic NOD mice which selectively expresses Cre in thymocytes 
during all phases of growth and development (Jax Lab: NOD.Lck-
cre). We hypothesize that the progression toward T1D should increase 
drastically in transgene positive F1 offspring compared to transgene 
negative controls. Prevention of diabetes can be tested by mating of 
floxed NOD-3×FLAG-mIR/MFM mice with commercially available 
NOD.FoxP3-cre mice (The Jackson Laboratory) to test the ability of 
T-regulatory cells to be delivered therapeutically via IR based chemo-
taxis. In addition to the potential use of these systems in migration and 
trafficking studies, these IR over-expression systems can be utilized 
in T1D IR auto-antibody studies to test for the presence of IR specific 
auto-antibodies and their ability to influence insulin binding and receptor 
stimulation as previously shown [20].
Understanding what triggers elicit insulitis and lymphocyte migra-
tion toward the pancreas during the pathogenesis of T1D holds strong 
therapeutic value. While antigenic determinants have long been inves-
tigated in the development of T1D, other modes of motility, such as 
chemotaxis, could be strong factors for initial lymphocyte trafficking 
toward the pancreas. Although the FVB/NJ-CD3-3×FLAG-mIR/MFM 
mice data strengthen the implications of chemotaxis based T-lymphocyte 
migration towards the pancreas, there are drawbacks to this system due 
to the low number of FLAG specific lymphocytes found in the periphery. 
In order to improve upon these drawbacks, the constitutive viral CAG 
promoter system will be used in combination with available models that 
selectively express Cre behind the strong lymphocyte protein tyrosine 
kinase (lck) promoter to ensure robust generation of high populations 
of mIR over-expressing T-lymphocytes. Understanding the driving 
force behind lymphocyte trafficking towards pancreatic islets during 
the progression of T1D is necessary in the design of novel therapeutic 
preventatives in the treatment of T1D.
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